Related Experiment Video
Updated: Aug 16, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Clinical challenges in the psychopharmacology of schizophrenia
1Chestnut Lodge Hospital, Rockville, MD 20850, USA.
Abstract:
Better pharmacological treatments for schizophrenia have elevated the expectations of patients and families and allow a wider range of therapeutic options for clinicians. At the same time, the treatment of schizophrenia has become more complex, and clinical decisions must often be made in the absence of unambiguous empirical guidelines. Under these circumstances, good patient care is based on clinical judgement informed by available clinical research. This issue of the Schizophrenia Bulletin reviews research in areas that represent major clinical challenges in the psychopharmacology of schizophrenia.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy
Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia

